FIGURE LEGEND
FIGURE 1 (A) Drop in CNS leukemic blast count and patient
weight after initiation of therapy (top); diagram of therapy provided
(bottom). ITT, intra-thecal triple therapy; Cyt, intrathecal cytarabine;
Cyt/HC, intrathecal cytarabine and hydrocortisone; DEX, dexamethasone;
6-MP, 6-mercaptopurine; VCR, vincristine. (B) Growth curve for
the patient showing rapid weight gain over a six-month period, with
resolution once CNS-directed therapy was initiated.